Effects of denosumab on bone mineral density and renal function in postmenopausal women transitioning from raloxifene

Patients who transitioned from raloxifene to denosumab showed good adherence with treatment and significant improvement in BMD in the spine and hip without a negative influence on renal function. Discussing the characteristics of both drugs and the best antiosteoporotic treatment with patients is critical for satisfactory results in the prevention of fractures.